MAB273

antibody from R&D Systems

Targeting: FGF9

ELISA (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Antibody Data

Product number

MAB273

Provider

R&D Systems

Product name

Anti-Human FGF-9 Monoclonal Antibody (Clone 36912)

Antibody type

Monoclonal

Antigen

S. frugiperda insect ovarian cell line Sf 21-derived recombinant human FGF-9, Met1-Ser208

Description

Protein A or G purified from ascites

Reactivity

Human

Host

Mouse

Antigen sequence

P31371


Isotype

IgG

Vial size

500 µg

References

Submitted references

FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells.

Sun C, Fukui H, Hara K, Zhang X, Kitayama Y, Eda H, Tomita T, Oshima T, Kikuchi S, Watari J, Sasako M, Miwa H
BMC cancer 2015 Apr 30;15:333

---

Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR
Cancer research 2006 Feb 1;66(3):1354-62

---

Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina.

Cinaroglu A, Ozmen Y, Ozdemir A, Ozcan F, Ergorul C, Cayirlioglu P, Hicks D, Bugra K
Journal of neuroscience research 2005 Feb 1;79(3):329-39

---

Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination.

Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B
Development (Cambridge, England) 2004 Aug;131(15):3627-36